Berbice Capital Management LLC Invests $78,000 in HCA Healthcare, Inc. (NYSE:HCA)

Berbice Capital Management LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, Holdings Channel.com reports. The firm acquired 260 shares of the company’s stock, valued at approximately $78,000.

Several other large investors have also recently bought and sold shares of the business. Brighton Jones LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $1,021,000. Red Door Wealth Management LLC increased its position in shares of HCA Healthcare by 1.5% in the fourth quarter. Red Door Wealth Management LLC now owns 21,659 shares of the company’s stock valued at $6,501,000 after buying an additional 321 shares in the last quarter. Galvin Gaustad & Stein LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $18,044,000. True North Advisors LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $373,000. Finally, Cetera Trust Company N.A increased its position in shares of HCA Healthcare by 1.1% in the fourth quarter. Cetera Trust Company N.A now owns 8,055 shares of the company’s stock valued at $2,418,000 after buying an additional 85 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of analyst reports. Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. KeyCorp cut their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their target price for the company from $400.00 to $320.00 in a report on Monday, November 25th. Finally, Oppenheimer raised their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $385.27.

Insider Transactions at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Up 0.1 %

Shares of HCA Healthcare stock opened at $325.54 on Friday. The stock’s fifty day moving average is $314.50 and its 200-day moving average is $352.84. The firm has a market capitalization of $82.46 billion, a PE ratio of 14.47, a price-to-earnings-growth ratio of 1.09 and a beta of 1.64. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12-month low of $279.93 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter in the prior year, the business earned $5.90 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 21.75 earnings per share for the current year.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.